1,590 results on '"GILLESPIE, G."'
Search Results
52. City to Soil: Returning Organics to Agriculture – A Circle of Sustainability
53. Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression
54. Combinatorial Drug Testing in 3D Microtumors Derived from GBM Patient-Derived Xenografts Reveals Cytotoxic Synergy in Pharmacokinomics-informed Pathway Interactions
55. Abstract 1430: N-cadherin is a driver of adaptive radioresistance in malignant brain tumors
56. Nursesʼ roles in screening for intimate partner violence: a phenomenological study
57. γ134.5-deleted HSV-1-expressing human cytomegalovirus IRS1 gene kills human glioblastoma cells as efficiently as wild-type HSV-1 in normoxia or hypoxia
58. Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study
59. Assessment of oncolytic HSV efficacy following increased entry-receptor expression in malignant peripheral nerve sheath tumor cell lines
60. A New Species of Large Eutropis (Scincidae) from Sulawesi, Indonesia
61. Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry study
62. Pharmacologic manipulations of mitochondrial membrane potential (ΔΨm) selectively in glioma cells
63. Abstract CT018: Phase I immunovirotherapy trial of oncolytic HSV-1 G207 alone or combined with radiation in pediatric high-grade glioma
64. Abstract 3078: IGF1/N-cadherin/b-catenin/Clusterin signaling axis can mediates adaptive radioresistance in glioblastoma
65. λ134.5-deleted HSV-1-expressing human cytomegalovirus IRS1 gene kills human glioblastoma cells as efficiently as wild-type HSV-1 in normoxia or hypoxia: This article has been corrected since advance online publication and an erratum is also printed in this issue
66. Measurements of in vivo intra-articular gentamicin levels from antibiotic loaded articulating spacers in revision total knee replacement
67. Large diameter femoral head uncemented total hip replacement to treat fractured neck of femur
68. Comparison of Genetically Engineered Herpes Simplex Viruses for the Treatment of Brain Tumors in a Scid Mouse Model of Human Malignant Glioma
69. Monoclonal Antibody Specific for the Transverse Tubular Membrane of Skeletal Muscle Activates the Dihydropyridine-Sensitive Ca2+ Channel
70. Membranes from T and B Lymphocytes Have Different Patterns of Tyrosine Phosphorylation
71. Feeding Behaviour and Impact of Ducks on Ripening Barley Crops Grown in Otago, New Zealand
72. Preclinical evaluation of an engineered oncolytic herpes simplex virus for pediatric osteosarcoma.
73. Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas
74. Increased oncolytic efficacy for high-grade gliomas by optimal integration of ionizing radiation into the replicative cycle of HSV-1
75. Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme
76. An early comparison of clinical and mechanical aspects of hybrid and uncemented hip resurfacing
77. Engineered herpes simplex viruses efficiently infect and kill CD133+ human glioma xenograft cells that express CD111
78. CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma
79. Capítulo 10 - Neoplasias malignas pediátricas
80. 0041 Coping and wellbeing for emergency department workers who experience workplace violence
81. 0042 Work productivity and stress of emergency nurses working with trauma patients
82. Safety and interim survival data after intracranial administration of M032, a genetically engineered oncolytic HSV-1 expressing IL-12, in pet dogs with sporadic gliomas
83. Glioma stem cells and their roles within the hypoxic tumor microenvironment
84. Evaluation of immunologic parameters in canine glioma patients treated with an oncolytic herpes virus
85. Enhanced antiglioma activity of chimeric HCMV/HSV-1 oncolytic viruses
86. Mutation of Escherichia coli cytosine deaminase significantly enhances molecular chemotherapy of human glioma
87. Directing adenovirus across the blood–brain barrier via melanotransferrin (P97) transcytosis pathway in an in vitro model
88. Effects of G207, a conditionally replication-competent oncolytic herpes simplex virus, on the developing mammalian brain
89. Engineered herpes simplex virus expressing bacterial cytosine deaminase for experimental therapy of brain tumors
90. Increased Expression of Thymidylate Synthetase (TS), Ubiquitin Specific Protease 10 (USP10) and Survivin is Associated with Poor Survival in Glioblastoma Multiforme (GBM)
91. Glucose Metabolism Heterogeneity in Human and Mouse Malignant Glioma Cell Lines
92. Enhanced inhibition of syngeneic murine tumors by combinatorial therapy with genetically engineered HSV-1 expressing CCL2 and IL-12
93. Radiation dosimetry of 131I-chlorotoxin for targeted radiotherapy in glioma-bearing mice
94. Changes in intracellular [Ca.sup.2+] and pH in response to thapsigargin in human glioblastoma cells and normal astrocytes
95. ETMR-22. TITLE: DEFINING THE CLINICAL AND PROGNOSTIC LANDSCAPE OF EMBRYONAL TUMORS WITH MULTI-LAYERED ROSETTES (ETMRs), A RARE BRAIN TUMOR REGISTRY (RBTC) STUDY
96. Exploring the Roles of lncRNAs in GBM Pathophysiology and Their Therapeutic Potential
97. Residential Greenness, Asthma, and Lung Function in Young Children
98. Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors
99. Oncolytic Viruses: Clinical Applications as Vectors for the Treatment of Malignant Gliomas
100. P17-28 LB. The antiviral efficacy of HIV-specific CD8+ T-cells to a conserved epitope is heavily dependent on the infecting HIV-1 isolate
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.